Please assess the completion status of the following clinical trial:

Trial Title: Vetal Laban Intervention Trial Assessing Bowel Symptoms

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females aged 18 to 65 years~* Subjects fulfilling Rome III criteria for IBS~* Sufficient health and orientation for participating in the trial~* Obtained his/her informed consent after verbal and written information.~* Have a high probability for compliance with and completion of the study.~* Body Mass Index (BMI) between 19 and 35.~Exclusion Criteria:~* Diagnosed or suspected organic gastrointestinal disease (i.e. colitis, Crohn's disease, celiac disease, major bowel surgery, recurrent diverticulitis) or severely impaired general health including cancer and cancer therapy.~* Lactose intolerance~* Unwillingness to refrain from probiotic use during the trial~* Use of antibiotics within the 3 preceding months prior to recruitment~* Pregnant, planning pregnancy or lactating~* Expected major lifestyle changes related to nutrition, exercise, travelling etc.~* Participation in a clinical trial with an investigational product or drug within 3 months prior to screening.~* Substance abuse~* Subjects unable to read and understand the questionnaires

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Vetal Laban active (Type: ACTIVE_COMPARATOR): Vetal Laban with L. acidophilus
- Placebo (Type: PLACEBO_COMPARATOR): Vetal Laban -like product without L. acidophilus

Based on this trial design, predict the completion outcome and termination type (if applicable).